UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update

Hepatology communications, 2021-11, Vol.5 (11), p.1824-1832

2021

Volltextzugriff (PDF)

Pediatric NAFLD: lessons from the gut

Hepatobiliary surgery and nutrition, 2020-08, Vol.9 (4), p.534-536

2020

Volltextzugriff (PDF)

The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)

Hormones (Athens, Greece), 2018-06, Vol.17 (2), p.219-229

2018

Volltextzugriff (PDF)

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study

PloS one, 2021-11, Vol.16 (11), p.e0260313-e0260313

2021

Volltextzugriff (PDF)

Human Immunodeficiency Virus and Fatty Liver: The Perfect Storm or a Storm in a Teacup?

Journal of acquired immune deficiency syndromes (1999), 2019-05, Vol.81 (1), p.e25-e26

2019

Volltextzugriff (PDF)

Sex is a major effect modifier between body composition and mortality in patients with cirrhosis assessed for liver transplantation

Liver international, 2023-01, Vol.43 (1), p.160-169

2023

Volltextzugriff (PDF)

Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies

Journal of acquired immune deficiency syndromes (1999), 2019-04, Vol.80 (4), p.474-480

2019

Volltextzugriff (PDF)

Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies

Journal of acquired immune deficiency syndromes (1999), 2019-04, Vol.80 (4), p.474

2019

Volltextzugriff (PDF)

Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension

Nutrition, metabolism, and cardiovascular diseases, 2022-12, Vol.32 (12), p.2839-2847

2022

Volltextzugriff (PDF)

Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis

Cochrane database of systematic reviews, 2020-01, Vol.1 (1), p.CD013123-CD013123

2020

Volltextzugriff (PDF)

Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis

Cochrane database of systematic reviews, 2021-03, Vol.3 (9), p.CD013122

2021

Volltextzugriff (PDF)

Comparison of point‐shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non‐alcoholic fatty liver disease

Liver international, 2022-10, Vol.42 (10), p.2195-2203

2022

Volltextzugriff (PDF)

Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis

Cochrane database of systematic reviews, 2021-04, Vol.4 (4), p.CD013121

2021

Volltextzugriff (PDF)

Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis

Cochrane database of systematic reviews, 2019-09, Vol.9 (9), p.CD013120

2019

Volltextzugriff (PDF)

Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low‐moderate liver fibrosis

Journal of viral hepatitis, 2020-11, Vol.27 (11), p.1214-1221

2020

Volltextzugriff (PDF)

The effects of a structured dietetics intervention in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S812-S813

2023

Volltextzugriff (PDF)

SAT-410 - Predictors of liver stiffness changes in consecutive cohorts of patients with non-alcoholic fatty liver disease and longitudinal follow-up

Journal of hepatology, 2023-06, Vol.78, p.S661-S662

2023

Volltextzugriff (PDF)

Predictors of liver stiffness changes in consecutive cohorts of patients with non-alcoholic fatty liver disease and longitudinal follow-up

Journal of hepatology, 2023-06, Vol.78, p.S661-S662

2023

Volltextzugriff (PDF)

FRI-471 - The effects of a structured dietetics intervention in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2023-06, Vol.78, p.S812-S813

2023

Volltextzugriff (PDF)

Myosteatosis and sarcopenia are prevalent in patients with NAFLD even in the absence of advanced fibrosis

Journal of hepatology, 2020-08, Vol.73, p.S149-S150

2020

Volltextzugriff (PDF)

THU018 - Myosteatosis and sarcopenia are prevalent in patients with NAFLD even in the absence of advanced fibrosis

Journal of hepatology, 2020-08, Vol.73, p.S149-S150

2020

Volltextzugriff (PDF)

Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2184-e2193

2021

Volltextzugriff (PDF)

PTU-041 Thromboelastography demonstrates a hypercoagulable profile in cirrhosis and correlates with liver disease severity

Gut, 2019-06, Vol.68 (Suppl 2), p.A132

2019

Volltextzugriff (PDF)

Assessment of non-alcoholic fatty liver disease

PloS one, 2021-11, Vol.16 (11), p.e0260313

2021

Volltextzugriff (PDF)

FRI423 - Statins use corrects the impact of direct acting antiviral agents on lipid profile in hepatitis C virus patients

Journal of hepatology, 2020-08, Vol.73, p.S607-S607

2020

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update

Pediatric NAFLD: lessons from the gut

The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study

Human Immunodeficiency Virus and Fatty Liver: The Perfect Storm or a Storm in a Teacup?

Sex is a major effect modifier between body composition and mortality in patients with cirrhosis assessed for liver transplantation

Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies

Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies

Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension

Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis

Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis

Comparison of point‐shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non‐alcoholic fatty liver disease

Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis

Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis

Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low‐moderate liver fibrosis

The effects of a structured dietetics intervention in patients with non-alcoholic fatty liver disease

SAT-410 - Predictors of liver stiffness changes in consecutive cohorts of patients with non-alcoholic fatty liver disease and longitudinal follow-up

Predictors of liver stiffness changes in consecutive cohorts of patients with non-alcoholic fatty liver disease and longitudinal follow-up

FRI-471 - The effects of a structured dietetics intervention in patients with non-alcoholic fatty liver disease

Myosteatosis and sarcopenia are prevalent in patients with NAFLD even in the absence of advanced fibrosis

THU018 - Myosteatosis and sarcopenia are prevalent in patients with NAFLD even in the absence of advanced fibrosis

Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection

PTU-041 Thromboelastography demonstrates a hypercoagulable profile in cirrhosis and correlates with liver disease severity

Assessment of non-alcoholic fatty liver disease

FRI423 - Statins use corrects the impact of direct acting antiviral agents on lipid profile in hepatitis C virus patients

Suchergebnisse filtern